Method for detecting and killing epithelial cancer cells
CA 2370741 A1 · Owner: Zila, Inc. · Inventors: Burkett, Douglas D.; Bernal, Samuel D.; Rose, Seth D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A diagnostic method for detecting cancerous epithelial cells by selectively marking the mitochondria of the cancer cells by delivering to the epithelium , a cationic supravital mitochondrial marking agent. Selective killing of cancerous epithelial cells in the presence of normal cells is effected by delivering a cationic supravital mitochondrial marking agent to epithelial cancer cells. The killing agent can also comprise the reaction product of the marking agent and a cancer chemotherapeutic drug or in admixture with drug.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.